Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page
- Check5 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.9%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check41 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check56 days agoChange DetectedOn November 19, 2024, new content was added, while on November 7, 2024, a significant section detailing data download options and study information fields was removed.SummaryDifference13%
- Check70 days agoChange DetectedOn November 7, 2024, the website was updated to version 2.12.2, introducing new download options for study data in various formats including CSV, JSON, and RIS, while the previous version 2.12.1 was removed.SummaryDifference16%
- Check77 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.